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G protein-coupled receptors (GPCRs) mediate
cellular responses to a variety of stimuli, but
how specific responses are regulated has
been elusive, as the types of GPCRs vastly out-
number the classes of G protein heterotrimers
available to initiate downstream signaling. In
our analysis of signaling proteins containing
DEP domains (90 residue sequence motifs
first recognized in fly Dishevelled, worm EGL-
10, and mammalian Pleckstrin), we find that
DEP domains are responsible for specific rec-
ognition of GPCRs. We examined the yeast reg-
ulator of G protein signaling (RGS) protein Sst2
and demonstrate that the DEP domains in Sst2
mediate binding to its cognate GPCR (Ste2).
DEP-domain-mediated tethering promotes
downregulation by placing the RGS protein in
proximity to its substrate (receptor-activated
Ga subunit). Sst2 docks to the Ste2 cytosolic
tail, but only its unphosphorylated state, allow-
ing for release and recycling of this regulator
upon receptor desensitization and internaliza-
tion. DEP-domain-mediated targeting of effec-
tors and regulators to specific GPCRs provides
a means to dictate the nature, duration, and
specificity of the response.
INTRODUCTION
DEP domains are found, often in tandem, in various pro-
teins involved in signal transduction. This conserved se-
quence element was first defined (Kharrat et al., 1998) in
three proteins: D. melanogaster Dishevelled (mammalian
ortholog Dvl), an adaptor in Wingless (Wnt) signaling;
EGL-10, a regulator of G protein signaling (RGS) protein
that negatively regulates signaling by G protein-coupledCell 1receptors (GPCRs) in C. elegans; and mammalian Pleck-
strin, which modulates signaling in platelets and neutro-
phils. In addition to pleckstrins, Dsh/Dvl, and the EGL-
10-related subfamily of RGS proteins, computational
analysis finds DEP domains in guanine nucleotide ex-
change factors (GEFs) for Rho-family GTPases of the
Dbl homology class, in certain GTPase-activating proteins
(GAPs), and in other signaling proteins (Burchett, 2000;
Wharton, 2003). Structures for DEP domains from mouse
Dvl1 (Wong et al., 2000) and Epac2 (a GEF for Rap
GTPases) (Rehmann et al., 2003) and human Pleckstrin
(Civera et al., 2005) reveal a conserved core comprising
a three-helix bundle and a b hairpin. DEP domains have
been implicated in membrane association (Pan et al.,
2004; Kovoor et al., 2005), but the physiological func-
tion and mechanism of this localization have remained
unresolved.
Of the five proteins in Saccharomyces cerevisiae with
predicted DEP domains, one is Sst2, which we previously
established to be the prototypic RGS protein (Dohlman
and Thorner, 1997). RGS proteins attenuate signaling ini-
tiated by agonist-occupied GPCRs by stimulating hydro-
lysis of the GTP bound to the Ga subunit of a receptor-ac-
tivated heterotrimeric G protein (Ross and Wilkie, 2000).
GPCRs mediate cellular responses to a large number of
stimuli, such as light, odors, tastes, peptide hormones,
chemokines, and neurotransmitters (Lefkowitz, 2004). In
yeast, the GPCR Ste2 initiates response to a peptide mat-
ing pheromone, a factor, by converting the associated
GDP-bound Gabg heterotrimer (Gpa1-Ste4-Ste18) to
free GTP-Gpa1 and a Ste4-Ste18 complex (Dohlman
and Thorner, 2001). Sst2 squelches signaling because
binding of its C-terminal RGS domain to GTP-Gpa1 stim-
ulates nucleotide hydrolysis (Apanovitch et al., 1998;
Dohlman et al., 1996), reforming GDP-Gpa1 and promot-
ing reassembly of inactive Gabg.
Although the hallmark of anRGSprotein is its conserved
core sequence (RGS domain), which is necessary and suf-
ficient for its GAP activity in vitro (Popov et al., 1997), we
found for Sst2 that even modest N-terminal truncations
(D1–55 and D1–125), far removed from its RGS domain26, 1079–1093, September 22, 2006 ª2006 Elsevier Inc. 1079
(420–689), totally ablated function in vivo (Dohlman et al.,
1996). The N terminus of Sst2 contains a canonical DEP
domain (279–358) preceded by a second DEP-like seg-
ment (50–135). Coexpression of an N-terminal fragment
(1–414) and a C-terminal RGS-domain-containing frag-
ment (415–698) complements the phenotype of sst2D
cells only very weakly (Hoffman et al., 2000); hence,
the N-terminal region contributes efficaciously to Sst2
function in cis to the RGS domain, but not in trans. As in
other DEP-domain-containing proteins, the N terminus
of Sst2 (and its worm ortholog, EGL-10) mediates mem-
brane targeting (Hoffman et al., 2000; Koelle and Horvitz,
1996); however, use of the two-hybrid method has failed
to identify a binding partner that is itself membrane
localized.
Here we describe our discovery of the function of the
DEP domains in Sst2. First, we show that even single point
mutations in the DEP elements inactivate Sst2 function.
Second, we find, conversely, that fusion of the Sst2 DEP
domains to a divergent RGS domain confers the ability
to act in the pheromone response pathway. Third, using
a loss-of-function point mutation in an unbiased selection
for dosage suppressors, we identify the physiologically
relevant interaction partner. Fourth, we confirm using bio-
chemical methods and cell imaging methods that the DEP
domains are necessary and sufficient for Sst2 binding to
this target. Finally, we show how this interaction contrib-
utes to desensitization and provide a mechanism for its
regulation.
RESULTS
DEP Domains Are Essential for Sst2 Function
The N-terminal portion of Sst2 contains a degenerate
(DEP-A) and a more canonical (DEP-B) DEP domain (Fig-
ure 1A). In DEP structures from Dvl1, Epac2, and Pleck-
strin 1, an upstream helix (a1) sandwiches a b hairpin
(b1-b2) between two downstream helices (a2 and a3). To
test whether either Sst2 DEP element is essential for its
function, portions of predicted helical segments in DEP-
A and DEP-B, and all of DEP-B, were deleted. Phero-
mone-initiated signaling blocks cell-cycle progression in
the G1 phase, which can bemonitored by a halo of growth
inhibition in a lawn of cells. Because Sst2 reverses G pro-
tein activation, it promotes recovery from this growth ar-
rest. When Sst2 is present, even a high dose of phero-
mone elicits only a small halo, whereas in an sst2D null
mutant, even a ten-fold lower dose produces a very large
halo (Figure 1B, left). All of the DEP-domain deletions,
even overexpressed from the strong GAL1 promoter, as
judged by immunoblotting (data not shown), caused
a phenotype as severe as the complete absence of Sst2
(Figure 1B, right). For less drastic perturbation, we intro-
duced double Pro substitutions into predicted a helices
in DEP-A and DEP-B and into the spacer between them
and tested them in the same way. These changes in
DEP-A or DEP-B also caused a defect as severe as an1080 Cell 126, 1079–1093, September 22, 2006 ª2006 Elseviersst2D mutation, whereas alteration of the intervening
region had a milder effect (Figure 1C). Thus, both DEP
elements in Sst2 are as important for its cellular function
as its RGS domain. Moreover, these data indicate that
DEP-A and DEP-B work cooperatively because alteration
of either was sufficient to cripple Sst2 function.
DEP Domains of Sst2 Direct Its RGS Activity
to the Pheromone Response Pathway
If the DEP domains in Sst2 target this regulator to its site of
action, we reasoned that attachment to another RGS
domain that normally does not function in pheromone
responsemight permit it to act on Gpa1-GTP. For this pur-
pose, we selected yeast Rgs2, which acts on the Ga
subunit (Gpa2) activated by a different GPCR (Gpr1) in
a glucose-sensing pathway (Versele et al., 1999). Indeed,
we found that, unlike overexpression of the DEP-domain-
containing fragment of Sst2 alone or the RGS-domain-
containing fragment of Rgs2 alone, the corresponding
Sst2-Rgs2 chimera was nearly as potent as native Sst2
in promoting recovery from pheromone-imposed growth
arrest, regardless of the strain background (Figure 2A).
Signal dampening by Sst2 also squelches expression of
a pheromone-inducible reporter gene, FUS1prom-lacZ
(Hoffman et al., 2002). This method was used to test effi-
cacy of a more extensive set of Sst2-Rgs2 chimeras (Fig-
ure 2B, upper left) in sst2D cells. If the specificity for Gpa1
resided in those portions of the Sst2 RGS domain that are
most divergent from those in the Rgs2 RGS domain, then
swapping those segments from Sst2 into Rgs2might con-
fer the desired specificity, which it did not (Figure 2B). In
contrast, attachment of the N-terminal DEP-domain-con-
taining segment of Sst2 to the RGS domain of Rgs2 (with
or without its C-terminal extension) squelched phero-
mone-induced reporter-gene expression even more
potently than wild-type Sst2 did (Figure 2B, lower right),
whereas the DEP domain of Sst2 alone was previously
shown to be ineffective in this same assay (Hoffman
et al., 2000). Thus, the specificity for RGS action against
Gpa1 resides primarily in the DEP-domain-containing
segment of Sst2.
Signaling by heterotrimeric G proteins starts at the
plasma membrane where GPCRs reside. Given the evi-
dence that other DEP domains mediate membrane asso-
ciation, they could represent a novel lipid-binding motif
that confers specificity simply by localizing Sst2 to the
membrane bilayer. Using surface plasmon resonance,
we found that the Sst2 N-terminal segment, but not its
RGS domain, has a propensity to interact with phospho-
lipids. This affinity for phospholipids is rather nonspecific
in comparison, for example, to the preference of a bona
fidePHdomain for PtdIns4,5P2 (see Figure S1A in theSup-
plemental Data availablewith this article online).Moreover,
fusion of a known membrane-targeting motif (N-myristoy-
lated and S-palmitoylated N-terminal ten residues of
Gpa1) to DEP-domain-defective sst2mutants (see below)
did not fully restore function (Figure S1B). Hence, although
lipid-binding propensity could contribute to DEP function,Inc.
Figure 1. DEP Domains in Sst2 Are Essential for Its Function
(A) The degenerate DEP-A and canonical DEP-B domains in Sst2 are aligned with ten others; three (1–3) have solved structures, whose secondary
structure elements are depicted.
(B) An sst2Dmutant (YDB100) was transformed with a low-copy (CEN) vector or the same vector expressing wild-type SST2 from theGAL1 promoter
or the indicated internal deletions (over- or underlined in [A]). Representative transformants were tested for sensitivity to pheromone-induced growth
arrest using an agar diffusion (halo) bioassay.
(C) The indicated double-Pro substitutions (boxed in [A]) were also tested, as in (B).Cell 126, 1079–1093, September 22, 2006 ª2006 Elsevier Inc. 1081
Figure 2. DEP Domains of Sst2 Confer Specificity for the Pheromone Response Pathway
(A) Ability of Sst2(1–406), Rgs2(30–309), or an Sst2(1–406)-Rgs2(30–309) chimera to complement an sst2D mutation was tested in two strain back-
grounds as in Figure 1B. The first 30 residues of Rgs2 were not included because they may exert an autoinhibitory effect on the RGS domain
(M. Versele, personal communication).1082 Cell 126, 1079–1093, September 22, 2006 ª2006 Elsevier Inc.
it seemed to us that the DEP domains of Sst2 might also
mediate interaction with a specific protein target.
Positive Selection for Loss-of-Function Alleles
Identifies a Critical DEP-Domain Residue
To implement a genetic approach for identifying potential
interaction partners, we first generated single point muta-
tions in theDEP-domain-containing region of Sst2 that dis-
rupt its function, but not its expression or stability. To do
so, we used error-prone PCR to generate an unbiased
library of DNA fragments mutagenized exclusively in the
DEP-domain region that were reintegrated into the SST2
coding sequence via in vivo repair of a suitably gapped re-
cipient plasmid (Figure S2A). We then devised and applied
a positive selection to identify loss-of-function alleles, and
candidates that expressed full-length Sst2 at a normal
level were identified, sequenced, and characterized as de-
scribed in Experimental Procedures. Two independently
isolated mutants carried different base pair changes alter-
ing the same residue (Q304E and Q304L), and both re-
sulted in complete loss of function. Modeling of Sst2
DEP-B on structures of the three knownDEPdomains pre-
dicts that Q304 is solvent exposed. It has been proposed
that the corresponding residue in mouse Dsh participates
in a dipole that is a good candidate for a protein-protein in-
teraction interface (Wong et al., 2000). Mutagenesis of the
equivalent residue in flyDshdisruptsWnt signaling (Penton
et al., 2002). We verified our results by introducing the
same substitutions, as well as Q304N, into otherwise pris-
tineSST2DNA using site-directedmutagenesis.When ex-
pressed at an endogenous level, even the conservative
substitutions (Q304N and Q304E) displayed nearly total
loss of function (Figure S2B), confirming that Q304 is criti-
cal. Q304NandQ304EcoimmunoprecipitatewithGpa1 as
well as wild-type Sst2 (data not shown). Importantly, we
noted that, when highly overexpressed (from a high-copy
plasmid and driven by the strong inducible GAL1 pro-
moter), Q304E and especially Q304N displayed significant
residual function (Figure S2C). This latter observation sug-
gested that we might be able to identify the protein target
that interacts with the DEP domain by screening for
dosage suppressors that restore Sst2 function when the
Q304N mutant is expressed at its normal level.
Positive Selection for Suppressors of Sst2(Q304N)
Identifies the GPCR Ste2
We reasoned that the defect in an Sst2 mutant specifically
crippled in its DEP domains, like the Q304N allele, might
be rescued, at least partially, if we overexpressed its bind-
ing partner from a multicopy plasmid. In this way, from a
library of such overexpressed genes, we might identify in
an unbiased way the protein that normally associates
with Sst2 via its DEP domains. Hence, we developed con-
ditions to positively select for restoration of Sst2(Q304N)Cell 1function (basically, ability to grow on an a factor concen-
tration that blocks growth of the Sst2(Q304N) mutant car-
rying empty library vector) and conducted a genome-wide
selection for dosage suppressors. Candidate colonies
were screened secondarily for those that only grew upon
exposure to pheromone in the presence of Sst2(Q304N),
but not in its absence. FromR20,000 initial transformants,
30 grew in the presence of pheromone, but just 6 permit-
ted growth only when Sst2(Q304N) was present. Upon re-
testing, only one of the six reproducibly permitted growth
in an Sst2(Q304N)-dependent manner. The plasmid res-
cued from this isolate contained six open reading frames;
one was the STE2 gene, which encodes the a factor re-
ceptor. To verify that STE2 was responsible for the sup-
pression observed, an independently constructed plas-
mid expressing only the STE2 gene from the strong
constitutive TDH3 promoter (David et al., 1997) was
tested. As judged by both the growth assay (data not
shown) and the halo assay (Figure 3A), overexpressed
Ste2 had no effect on pheromone sensitivity of sst2D cells,
but, like the library isolate, it significantly reduced phero-
mone sensitivity of cells expressing Sst2(Q304N). As
judged by immunoblotting (Figure 3B), this effect could
not be attributed to any elevation in the level of the mutant
Sst2 protein in the absence or presence of a factor. (SST2
is a pheromone-inducible gene [Dohlman et al., 1996].) As
expected for rescue arising from authentic protein-protein
interaction, suppression was allele specific. Ste2 overex-
pression ameliorated significantly only the pheromone
sensitivity of cells expressing Sst2(Q304N) (the allele
with the greatest residual function) and not Sst2(Q304E)
or Sst2(Q304L) (data not shown).
Ste2 Physically Associates with Sst2 via
Its DEP Domains
We found, first, that endogenous Ste2 detergent solubi-
lized from purified plasma membranes, regardless of its
state of N-glycosylation, binds to c-Myc epitope-tagged
Sst2 immobilized on beads using anti-mycmAb 9E10 (Fig-
ure 4A). Interaction was specific because no bound spe-
cies were observed if beads lacked Sst2 or if membrane
extractswereprepared from ste2Dcells.Most importantly,
no Ste2 was retained when beads were coated with an
equivalent amount of Sst2(Q304N) (Figure 4A). No detect-
able Gpa1 was present in the pull-down, as judged by im-
munoblotting with an anti-Gpa1 antibody (Dohlman et al.,
1993). We found, second, that His6-Sst2 (produced by ba-
culovirus expression and purified by FPLC) bound to
FLAG-tagged Ste2 (detergent solubilized from plasma
membranes of sst2D ste2D gpa1D ste4D cells) immobi-
lized on beads with anti-FLAG epitope mAb (Figure 4B).
Taken together, these in vitro data show that Sst2 binds di-
rectly to Ste2 in a DEP-dependent (but not Gpa1-depen-
dent) manner.(B) Sst2 or the indicated Sst2-Rgs2 chimeras (upper left), expressed from the ADH1 promoter on a CEN plasmid in sst2D cells, were tested for their
efficacy in squelching pheromone-induced expression of a reporter gene (remaining panels). Data shown are representative of three independent ex-
periments. Values givenare averagesof samples (assayed in triplicate) for a typical experiment; error bars indicate the standarderror of themean (SEM).26, 1079–1093, September 22, 2006 ª2006 Elsevier Inc. 1083
Figure 3. Overexpression of Ste2 Ameliorates the Defect of an Sst2 DEP-Domain Mutant
(A) YDB100 (sst2D leu2D ura3D) (left panels) carrying an empty URA3-marked CEN vector (left column) or the same vector expressing myc-
Sst2(Q304N) (right column) was transformed with empty LEU2-marked library vector (YEp13) (top row) or the dosage suppressor isolated from a
genomic library in the same vector (bottom row). YDM400 (sst2D trp1D ura3D) (right panels) carrying the same CEN vector lacking (left column) or
expressing myc-Sst2(Q304N) (right column) was transformed with empty TRP1-marked vector (YEplac112) (top row) or a TRP1-marked multicopy
(2 mm DNA) plasmid expressing STE2 from the strong constitutive TDH3 promoter (bottom row). For comparison, YDB100 and YDM400 were trans-
formed with aURA3-markedCEN vector expressing wild-typemyc-Sst2 (center, left, and right panels). All were tested for pheromone sensitivity as in
Figure 1B.
(B) Cells expressing myc-Sst2(Q304N) with or without overexpressed Ste2 in either the absence or presence of pheromone were lysed, resolved by
SDS-PAGE, and analyzed by immunoblotting with anti-c-Myc mAb 9E10.To corroborate this conclusion in a physiological set-
ting, we used the split-ubiquitin two-hybrid method that
was developed to assess interaction of membrane-asso-
ciated proteins (Fetchko and Stagljar, 2004). One protein
is fused to an N-terminal (N-UbG) fragment defective for
association with a C-terminal (C-Ub) fragment that is
fused to the other protein (Figure 4C). Interaction between
the proteins forces ubiquitin reassembly. If reassembled,
ubiquitin C-terminal hydrolases clip off a transcription fac-
tor (LexA-VP16) fused to the C terminus of C-Ub. Once
freed from its membrane tether, LexA-VP16 enters the nu-
cleus and induces expression of a lacZ reporter gene with
LexA binding sites. Our tester cells all expressed an Ste2-
C-Ub-LV fusion and coexpressed association-defective
N-UbG alone, wild-type Sst2-N-UbG, or each Sst2 DEP-
domain mutant fused to N-UbG. Every transformant ex-
pressing Sst2-N-UbG and Ste2-C-Ub-LV showed robust
reporter-gene expression at a level equivalent to that of1084 Cell 126, 1079–1093, September 22, 2006 ª2006 Elseviethe positive control (Figure 4D). For this control, cells
were cotransformed with an Ste2-N-UbI chimera that
binds Ste2-C-Ub-LV for two reasons: N-UbI interacts con-
stitutively with C-Ub, and Ste2 self-associates to form
dimers (Overton et al., 2003). Most importantly, like the
negative control expressing N-UbG alone, no reporter ex-
pression was seen when Sst2-N-UbG carried any Q304
mutation (Figure 4D). As a specificity control, two other
GPCR-C-Ub-LV fusions were tested for interaction with
Sst2-N-UbG, V2 vasopressin receptor, and calcitonin
receptor. These receptor-C-Ub-LV chimeras displayed
a somewhat higher background than Ste2-C-Ub-LV alone
did; however, unlike Ste2-C-Ub-LV, neither showed any
enhancement of reporter-gene expression in the presence
of Sst2-N-UbG or any of the DEP-domain mutants (data
not shown). Thus, interaction of Sst2 with Ste2 was only
observed with this specific GPCR-RGS protein pair and
was DEP domain dependent.r Inc.
Figure 4. Sst2 Binds Ste2 via Its DEP Domain Both In Vitro and In Vivo
(A) Ste2 solubilized with 0.5% n-dodecyl-beta-D-maltopyranoside (DoBM; Calbiochem, San Diego, CA, USA) from plasma membranes isolated by
sucrose-gradient flotation from YDB100 (sst2D) (+) (input, 5% of total added) or a control from YDB105 (sst2D ste2D) () was incubated with anti-c-
Myc antibody-decorated Protein A/G beads coated with myc-Sst2(WT) or myc-Sst2(Q304N) expressed from the GAL1 promoter on a CEN vector in
YDB104 (sst2D ste2D ste4D gpa1D), a derivative of a protease-deficient strain (BJ2168), or with an identical extract of YDB104 expressing empty
vector (). After washing, bound proteins eluted in 5% SDS sample buffer at 37C and resolved by SDS-PAGE were analyzed by immunoblotting
with rabbit polyclonal anti-Ste2 antibodies (upper panel) or mouse anti-c-MycmAb 9E10 (bottom panel). A representative experiment (n = 3) is shown
in which the indicated controls were run in parallel; to permit side-by-side comparison, the input and one other lane were moved from their original
position in the gel and are therefore in separate boxes.
(B) The indicated amounts of His6-Sst2, produced by baculovius expression and purified by FPLC, were incubated with anti-FLAG mAb M2-deco-
rated beads or the same beads coated with a DoBM extract of plasmamembranes from YDB118 (ste2D sst2D gpa1D ste4D) expressing pYES-STE2-
FLAG. After washing and elution with FLAG peptide, released proteins were analyzed by immunoblotting with anti-His6 (QIAGEN) and a rabbit poly-
clonal anti-FLAG IgG (Sigma).
(C) Split-ubiquitin two-hybrid method (Fetchko and Stagljar, 2004) to assess the ability of fusions of Sst2, Sst2(Q304N), Sst2(Q304E), and Sst2(Q304L)
to N-UbG to interact with Ste2-C-Ub-LV.
(D) As a negative control (left), the ability of N-UbG alone to interact with Ste2-C-Ub-LV was tested. As a positive control (right), the ability of Ste2-
N-UbI to interact with Ste2-C-Ub-LV was tested. N-UbI versus N-UbG refers to an I13G mutation, which prevents spontaneous association of N-Ub
and C-Ub.Cell 126, 1079–1093, September 22, 2006 ª2006 Elsevier Inc. 1085
Sst2 Binds via Its DEP Domains to the Cytosolic
Tail of Ste2
To demonstrate that Sst2 and Ste2 interact in vivo and fol-
low the dynamics of their association in real time in live
cells, we constructed a fully functional fusion of Sst2 to
GFP. For expression at its endogenous level, this construct
was integrated into the SST2 chromosomal locus inMATa
cells, and its subcellular localization was examined using
confocal fluorescence microscopy. To rule out any contri-
bution of the interaction of the Sst2 RGS domain with its
GTP-bound Ga substrate (Gpa1), the GPA1 locus was
replaced with GPA1(G302S), a mutation that abrogates
Gpa1 binding to the Sst2 RGS domain but does not other-
wise perturb its function (DiBello et al., 1998). When
exposed to a factor, cells underwent the expected phero-
mone-induced morphogenesis and formed the character-
istic pear shape (‘‘shmoo’’). Concomitantly, Sst2-GFPwas
recruited prominently to the tip of the shmoo (Figure 5A),
where it has been amply demonstrated previously that
newly made Ste2 and other integral membrane proteins
are inserted (Heiman and Walter, 2000; Dohlman and
Thorner, 2001). Under identical conditions, Sst2(Q304N)-
GFP was not recruited to the shmoo tip, indicating that in-
tact DEP domains are required for binding of Sst2 to Ste2.
Consistent with this conclusion, wild-type Sst2-GFP was
never observed at the tips of the shmoos that form sponta-
neously at a high frequency in ste2Dcells (Figure 5A). (Such
morphogenesis occurs because absence of receptor
destabilizes the associated Gabg heterotrimer, causing
stochastic firing of the pheromone response pathway
[Reneke et al., 1988; Siekhaus and Drubin, 2003].)
To demonstrate colocalization of Sst2 and Ste2 directly
and the role of the DEP domains in their association, Sst2-
GFP was introduced into strains in which chromosomally
expressed Ste2 was fused to mCherry, a variant of
mRFP (Shaner et al., 2004). In otherwise wild-type cells
and even in the absence of pheromone, Ste2-mCherry un-
dergoes robust constitutive ubiquitin-dependent endocy-
tosis (Hicke et al., 1998; Katzmann et al., 2004). Thus, as
expected, the bulk of the red fluorescence resides in the
lysosome-like vacuole. We also noted prominent green
fluorescence in the perivacuolar region, as expected if at
least some of the Sst2 is internalized from the cytosolic
face of the plasma membrane along with Ste2 (Figure 5B,
top panels). To prevent constitutive endocytosis, seven
Lys residues in the cytosolic tail of Ste2-mCherry that pro-
mote endocytosis were mutated to Arg (Terrell et al.,
1998). Indeed, as expected, Ste2(7K-to-R)-mCherry dis-
played prominent decoration of the plasma membrane
(Figure 5B, lower panels). Most strikingly, the Sst2-GFP
signal nowwas alsomost pronounced at the plasmamem-
brane (Figure 5B, lower panels). Thus, localization of Sst2-
GFP trackedwith localization of Ste2-mCherry (Figure S3),
as expected for two proteins that associate rather stably
and with high affinity. When identical experiments were
conducted using Sst2(Q304N)-GFP (Figure 5C), green
fluorescence remained exclusively in the cytosol, even in
the cells expressing Ste2(7K-to-R)-mCherry (Figure 5C,1086 Cell 126, 1079–1093, September 22, 2006 ª2006 Elsevielower panels). Thus, colocalization of Sst2 with Ste2 re-
quires the function of its DEP domains.
We demonstrated before that deleting the C-terminal
cytosolic tail (residues 297–431) of Ste2 prevents its endo-
cytosis and also that such a C-terminally truncated recep-
tor confers an elevated level of sensitivity to pheromone,
comparable to that of an sst2D mutation (Konopka et al.,
1988; Reneke et al., 1988). We found that an mCherry de-
rivative of tailless Ste2 was still located in the plasma
membrane, as expected, whereas Sst2-GFP in the same
cells was located exclusively in the cytosol (Figure 6A),
contrary to its clear plasma membrane association in cells
expressing mCherry-tagged full-length Ste2(7K-to-R).
Hence, the cytosolic tail of Ste2 is necessary for recruit-
ment of Sst2 in vivo. The Ste2 tail is also sufficient to
bind Sst2. In cells lacking native Ste2,GAL1-promoter-ex-
pressed Ste2(297–431)-mCherry, tethered to the plasma
membrane via its fusion to Gpa1(1–10), recruited endoge-
nously expressed Sst2-GFP to the cell membrane, espe-
cially in the bud (Figure 6B, upper panels). Although
expression of Sst2-GFP is drastically reduced in the
absence of basal G protein-dependent signaling (Roberts
et al., 2000), even with a constitutively active MAPKKK
(STE11-4 allele) present, production of the tail chimera
brings some Sst2-GFP to the membrane in cells lacking
both Ste2 and Gpa1 (Figure 6B, lower panels).
To examine the generality of these findings for another
GPCR, we tested whether Ste3 (the a factor receptor of
MATa cells) associates with Sst2 (because an sst2Dmuta-
tion makes MATa cells hypersensitive to a factor). As ob-
served for Ste2 (Figure 5B), preventing ubiquitylation and
endocytosis of Ste3 with 3K-to-R mutations greatly in-
creased the amount of Sst2 recruited to the plasma mem-
brane (Figure S4). The C-terminal tails of Ste2 and Ste3
bear little discernible sequence identity, suggesting that
the element recognized by Sst2 in each receptor is not
a simple sequence motif.
Phosphorylation of the Cytosolic Tail of Ste2
Displaces Sst2
We noted that, in naive cells, both endocytosis-defective
Ste2(7K-to-R)-mCherry and Sst2-GFP colocalize at the
plasma membrane all around the perimeter of the cell
(Figure 5B and Figure 6A). In contrast, by the time cells
form prominent shmoos after exposure to pheromone,
the Sst2-GFP concentrates at the tip of the shmoo and
does not associate with the Ste2(7K-to-R)-mCherry else-
where in the plasma membrane (Figure 6C, upper panels).
Prior work has shown that pheromone binding to receptor
promotes phosphorylation of its cytosolic tail by two
membrane-anchored casein kinase I isoforms (Yck1 and
Yck2) (Feng and Davis, 2000) as a prerequisite to en-
hanced ubiquitylation and endocytosis (Chen and Ko-
nopka, 1996; Hicke et al., 1998). Because Ste2(7K-to-R)-
mCherry cannot undergo endocytosis, we presumed
that, once phosphorylated, this receptor remains in the
membrane but is displaced from the shmoo tip by newly
incorporated, unliganded receptor, which has the leastr Inc.
Figure 5. Sst2 Colocalizes with Ste2
(A) An exponentially growing culture of
a Gpa1(G302S) mutant (which abrogates bind-
ing of the Sst2 RGS domain) with Ste2 or
without (ste2D) and expressing Sst2-GFP or
Sst2(Q304N)-GFP from the SST2 promoter at
its chromosomal locus was treated with 500
nM a factor for 1 hr and examined by confocal
fluorescence microscopy.
(B) An exponentially growing culture of
a Gpa1(G302S) mutant expressing Sst2-GFP
as in (A) and also coexpressing from the STE2
promoter at its chromosomal locus either
Ste2-mCherry (upper two rows) or endocyto-
sis-defective Ste2(7K-to-R)-mCherry (bottom
two rows) was examined as in (A), but in the
absence of any pheromone treatment.
(C) As in (B), except that the cells expressed
Sst2(Q304N)-GFP. Representative cells are
shown in all panels.opportunity to undergo any posttranslational modification.
Hence, we reasoned that phosphorylation of the Ste2
cytosolic tail might prevent Sst2 docking and thus be
responsible for the pattern observed. Indeed, in cells ex-
posed to pheromone, but in which Yck1- and Yck2-medi-
ated phosphorylation was ablated by appropriate muta-
tions, Sst2-GFP associated with Ste2(7K-to-R)-mCherry
around the entire perimeter of the cells (Figure 6C, middle
panels). To demonstrate that the relevant target of Yck1
and Yck2 that prevents Sst2 interaction is the cytosolic
tail of Ste2 itself, rather than any other potential substrate,
we mutated all 19 of the Ser and Thr residues in the region
of the tail that has been delimited by prior work as contain-
ing the physiologically relevant phosphorylation sites
(Chen and Konopka, 1996; Hicke et al., 1998). In the
cells expressing Ste2(7K-to-R, 19S/T-to-A)-mCherry, theCellSst2-GFP signal was now congruent with the red fluores-
cence (Figure 6C, bottom panels) in every cell, unlike cells
expressing Ste2(7K-to-R)-mCherry, where the Sst2-GFP
is located exclusively at the shmoo tip (Figure 6C, upper
panels). Thus, agonist-stimulated phosphorylation of the
Ste2 cytosolic tail is responsible for dissociating Sst2 prior
to the ligand-induced endocytosis of this receptor.
DISCUSSION
We used experimental advantages of yeast cells to dis-
cern the function of DEP domains in the prototypic RGS
protein Sst2. Given that DEP domains are found in pro-
teins that participate in signaling, and given how exten-
sively studied signaling pathways are, it is surprising that
a physiological role for DEP domains had not previously126, 1079–1093, September 22, 2006 ª2006 Elsevier Inc. 1087
Figure 6. Sst2 Associates with the Unphosphorylated State of the Cytosolic Tail of Ste2
(A) An exponentially growing culture of a Gpa1(G302S) mutant expressing Sst2-GFP as in Figure 5 and also coexpressing from the STE2 promoter at
its chromosomal locus either endocytosis-defective Ste2(7K-to-R)-mCherry (upper two rows) or endocytosis-defective Ste2(D296)-mCherry (bottom
two rows) was examined as in Figure 5.
(B) Otherwise wild-type cells (YDB120) expressing Sst2-GFP as in Figure 5 and also coexpressing from the GAL1 promoter at the STE2 locus
a Gpa1(1–10)-Ste2(297–431)-mCherry chimera were grown on glucose (upper panels) or induced with galactose (lower panels), and examined as
in (A). YDB122 (gpa1D ste4D [YCp50-STE11-4]) expressing the Gpa1(1–10)-Ste2(297–431)-mCherry chimera and weakly expressing Sst2-GFP
was analyzed as in (A).
(C) An exponentially growing culture of a Gpa1(G302S) mutant expressing Sst2-GFP and endocytosis-defective Ste2(7K-to-R)-mCherry (upper
panels) or carrying the yck1D yck2ts mutations (middle panels) was shifted to restrictive temperature (37C), treated with 500 nM a factor for 1 hr,1088 Cell 126, 1079–1093, September 22, 2006 ª2006 Elsevier Inc.
been defined. We demonstrated, first, that the DEP do-
mains are as necessary for Sst2 function as its hallmark
RGS domain. We then showed that the Sst2 DEP domains
are sufficient to confer on a distantly related (40% similar-
ity) RGS domain efficient action on Gpa1-GTP. By con-
trast, membrane targeting of the Sst2 RGS domain via
other means only inefficiently complemented an sst2D
mutation. Likewise, mammalian RGS4 (a small ‘‘RGS-do-
main-only’’ protein) was first isolated by its ability to re-
duce pheromone hypersensitivity of sst2D cells (Druey
et al., 1996), and this weak rescue required the N-terminal,
basic, amphipathic membrane-binding a-helix of RGS4
(Srinivasa et al., 1998). These differences in potency sug-
gested to us that the DEP domains of Sst2 must do more
than just tether this RGS protein to the cell membrane.
Nonetheless, our surface plasmon resonance results
showed that the Sst2 DEP domains have phospholipid-
binding propensity in vitro, consistent with the membrane
binding reported for other DEP domains in vivo. Basic res-
idues cluster on a surface of the DEP domain of mouse
Dvl1 distinct from its proposed protein-protein interaction
interface (Wong et al., 2000). Modeling indicates that the
Sst2 DEP domains also have a basic surface, which may
mediate binding to phosphates in the head groups of
phospholipids, explaining its observed affinity for mem-
branes (Dohlman et al., 1996).
Because itsDEPdomainsarenecessary andsufficient to
direct Sst2 selectively to the pheromone response path-
way, it seemed likely that these domains also interact
with a specific protein target in that pathway. To use ge-
netic means to identify that component, we identified con-
servative substitutions at a single residue (Q304) in DEP-B
that severely crippled Sst2 but retained residual function
(revealed when the protein was markedly overexpressed).
Basedonthe fact thatcomplex formationbetweenamutant
protein and its normal bindingpartner canoftenbe restored
throughmass action by greatly elevating expression of that
partner, we then selected for dosage suppressors of the
mutant Sst2(Q304N) using a genomic DNA library ex-
pressed at a high level from a multicopy plasmid. This ap-
proach yielded one candidate, the a factor receptor (Ste2).
We confirmed the authenticity of this finding in multiple
ways. First, we demonstrated that detergent-solubilized
Ste2 binds in vitro to immobilized Sst2 and that Q304N
eliminates that binding. No Gpa1 was detectable in these
pull-downs. Second, we found that purified recombinant
Sst2 bound to immobilized Ste2 immunopurified from
cells lacking Gpa1. Thus, Sst2 and Ste2 bind directly.
Third, using the split-ubiquitin two-hybrid method, we
showed that Sst2 and Ste2 associate in vivo and that
mutations of Q304 prevented this interaction. Fourth, we
demonstrated using differentially tagged fluorescent de-
rivatives of Ste2 and Sst2 that this regulator (but not the
Q304N mutant) colocalizes with its cognate receptor.Cell 1Moreover, we showed that the C-terminal cytosolic tail of
Ste2 is necessary and sufficient for tethering Sst2 in vivo
and that this interaction is disrupted by the Q304N muta-
tion. Finally, we found that Sst2-Ste2 interaction is con-
trolled by phosphorylation; Sst2 binds to the unphos-
phorylated tail of the receptor and cannot bind when the
tail has undergone pheromone-induced phosphorylation.
In hindsight, it makes satisfying physiological sense that
an RGS protein directly couples to the receptor that acti-
vates the G protein on which this regulator must act.
One function of this DEP-domain-mediated anchoring to
Ste2 is to ensure that the Sst2 RGS domain is situated in
close proximity to its substrate, permitting immediate
and efficient action (Figure 7). Thus, to ensure robust
and sustained response to agonist, enough pheromone
needs to be added to activate a sufficient number of
receptors to outpace the amount of Sst2 initially present.
Indeed, there is experimental evidence that basal Sst2
expression is adequate to squelch any Ga released by
spontaneousGprotein dissociation and sets the threshold
of receptor activation required to trigger pheromone
response (Siekhaus and Drubin, 2003). However, as men-
tioned earlier, Sst2 expression is highly induced by pher-
omone (Dohlman et al., 1996), providing a negative feed-
back loop to impose efficient downregulation after the
initial response (Figure 7).
Based on much evidence, GPCRs associate primarily
via their third intracellular loop with the Ga subunit of the
coupled G protein, and Ste2-Gpa1 interaction is no ex-
ception to this general rule (Konopka and Thorner,
2004). However, there is genetic evidence that the cyto-
solic tail of Ste2 also interacts with Gpa1 in a ‘‘preactiva-
tion complex’’ (Figure 7), which contributes to preventing
spurious agonist-independent G protein activation (Dosil
et al., 2000). Consistent with this view, a dominant-nega-
tive mutant, Gpa1(N388D), appears to exert its effects
via tighter binding to Ste2 (Wu et al., 2004) and may thus
form a preactivation complex more stable than normal
Gpa1. However, the wild-type interaction must be of rela-
tively low affinity and must not occlude the Sst2 binding
site because we clearly showed that Sst2 binds well to
the receptor tail even when pheromone is absent. In
agreement with the conclusion that Ga and Sst2 binding
to the receptor are not mutually exclusive, addition of
a 10- to 20-fold molar excess of Sst2 in pull-down assays
does not detectably diminish the amount of Ste2 that
binds to immobilized Gpa1(G302S) (unpublished data).
The fact that DEP-domain-mediated docking of Sst2 to
the cytosolic tail of Ste2 is required for this negative regula-
tor to carry out its function explains our prior observations
that deletion of the Ste2 tail causes an increase (300-fold)
in pheromone sensitivity essentially equivalent to that
caused in wild-type cells by an sst2D mutation and that
sst2D cells expressing Ste2(D296) are only slightly moreand examined as in (A). An exponentially growing culture of a Gpa1(G302S) mutant coexpressing Sst2-GFP and a derivative of Ste2(7K-to-R)-
mCherry that lacks 19 phosphorylation sites in the sequence from Ser331 to Thr425 (lower panels) was treated with 500 nM a factor for 1 hr and
examined as in (A). Representative cells are shown in all panels.26, 1079–1093, September 22, 2006 ª2006 Elsevier Inc. 1089
Figure 7. Model for DEP-Domain Function during Sst2-Mediated Desensitization
Dotted lines depict transition states; crosses mark disrupted interactions. See Discussion for further details.pheromone sensitive (%10-fold) than either single mutant
alone (Reneke et al., 1988). Perhaps the slightly additive
effect represents elimination of the role that interaction of
the cytosolic tail with Gpa1 plays in stabilization of the pre-
activation complex (Figure 7). One prediction of our find-
ings is that Ste2(D296) should be more hypersensitive to
pheromone action than any other alteration of the tail that
we generated in this study, and this is the case (Figure S5).
Upon exposure to pheromone, we presume that ago-
nist-induced conformational changes in the receptor re-
lieve the constraints imposed by the preactivation com-
plex and simultaneously facilitate interactions required
for the receptor to exert its GEF activity on its associated
G protein, releasing GTP-Gpa1 and the Gbg complex (Fig-
ure 7). When the number of occupied receptors exceeds
the amount of Sst2 present to reverse G protein activation,
released Gbg (which in yeast is the effector necessary to
trigger downstream events [Dohlman and Thorner,
2001]) elicits pathway response, including induction of
SST2 and other pheromone-responsive genes (Figure 7).
As the intracellular Sst2 concentration increases, it will
be recruited to more and more receptors, where docking
via its DEP domains positions its RGS domain to act opti-
mally on any GTP-Gpa1 still being produced, thereby con-
tributing to reformation of inactive G protein heterotrimers
and downregulation of signaling. The same pheromone-
induced conformational changes in Ste2 that establish
its signaling-competent state also expose its cytosolic1090 Cell 126, 1079–1093, September 22, 2006 ª2006 Elsevtail to phosphorylation by Yck1 and Yck2, which are
plasma membrane-tethered by C-terminal S-palmitoyla-
tion (Feng and Davis, 2000). Phosphorylation concomi-
tantly prevents Sst2 binding and serves as the signal to re-
cruit the ubiquitin ligase that further modifies the receptor
to trigger endocytosis (Hicke et al., 1998). Thismechanism
recycles Sst2, avoiding nonproductive interaction with re-
ceptors already en route to destruction (Figure 7).
Here we have showed that DEP domains in the RGS
protein Sst2 are responsible for its specific recognition
of a GPCR, Ste2. Direct association of an RGS protein
with its cognate receptor provides a biologically sensible
mechanism for achieving highly selective desensitization
of any given GPCR-initiated pathway. It is likely, therefore,
that other members of the RGS protein family, including
worm EGL-10 and mammalian RGS6, RGS7, RGS9, and
RGS11, which are expressed in the nervous system, asso-
ciate with their cognate GPCRs (e.g., opioid and dopa-
mine receptors) via DEP-domain-mediated contacts.
Also, we suspect that DEP domains in fly Dsh and its
mammalian Dvl orthologs associate with the GPCR-like
receptor Frizzled in the Wnt signaling pathway and may
be part of the switch that directs signals to the canonical
Wnt-initiated b-catenin pathway or the planar cell polar-
ity/convergent extension pathway, both of which require
Dsh/Dvl (Huang and Klein, 2004). Likewise, DEP domains
in the RacGEFP-Rex-1maymediate its direct association
with the C5a receptor, a GPCR in neutrophils, whichier Inc.
stimulates the Gbg-dependent activation of this exchange
factor. Similar rationales can be invoked to explain why it
would be physiologically reasonable for other types of
DEP-domain-containing signaling proteins to specifically
dock onto the GPCRs that initiate response in the path-
ways in which those proteins participate. In fact, se-
quence divergence among DEP domains may reflect the
role they play in directing regulators and downstream ef-
fectors to the large array of GPCRs, which in metazoans
are the single largest superfamily of gene products known.
In the absence of a DEP domain, downstream compo-
nents in GPCR-initiated pathwaysmay have evolved other
means to interact directly with their corresponding
GPCRs. For example, RGS12 binds via a PDZ domain to
the C terminus of CXCR2 (interleukin-8 receptor) (Snow
et al., 1998), and RGS2 associates with the third intracel-
lular loop of selected GPCRs (Hague et al., 2005). Alterna-
tively, juxtaposition to cognate GPCRs can be mediated
by contacts to other integral membrane proteins—for ex-
ample, RGS7 interacts with the SNARE-like protein R7BP
(Drenan et al., 2005; Martemyanov et al., 2003).
Although the DEP-domain-mediated interaction of Sst2
with the cytosolic tail of Ste2 places this RGS protein in
close proximity to the Ga subunit it downregulates, it
may serve other functions. One possibility is that Sst2
binding to Ste2 might also contribute to desensitization
by sterically occluding G protein reassociation with the re-
ceptor, but, as mentioned above, our biochemical exper-
iments make this an unlikely scenario. However, it is pos-
sible that binding of Sst2 contributes to downmodulation
of signaling by inhibiting the ability of Ste2 to act as a pher-
omone-activated GEF. Our in vitro experiments in this re-
gard have so far been inconclusive. In any event, DEP-do-
main-mediated interaction of Sst2 with the cytosolic tail of
Ste2 achieves selective targeting of this regulator to its site
of action and to its specific substrate, thereby ensuing that
the GAP activity of its RGS domain acts efficaciously.
EXPERIMENTAL PROCEDURES
Yeast Strains and Growth Conditions
Cultivation of strains (Table S1) was at 30C (unless otherwise indi-
cated) in standard rich (YP) or defined minimal (SC) media containing
2% glucose (Glc), 2% raffinose with 0.2% sucrose (Raf/Suc), or 2%
galactose (Gal) as required and supplemented with appropriate nutri-
ents to maintain selection for plasmids where necessary. Standard
yeast genetic techniques were used.
Plasmids and Recombinant DNA Methods
Plasmids (Table S2) were constructed and propagated in Escherichia
coli, and site-directed mutagenesis using appropriate mismatch oligo-
nucleotide primers was conducted, using standard recombinant DNA
methods. Fidelity of all constructs was verified by nucleotide sequence
analysis. Standard polymerase chain reactions (PCR) utilized Turbo
Pfu DNA polymerase (Stratagene, La Jolla, CA, USA).
Assay of Sst2 Function
Sst2 action in vivo was assessed by its ability to reverse pheromone-
induced growth inhibition using an agar diffusion (halo) bioassay
(Reneke et al., 1988) in which filters were spotted with 15 ml of either
a 0.1 mg/ml (59.3 mM) or 1 mg/ml stock (593 mM) of a factor or by itsCell 1ability to squelch induction of a plasmid-borne pheromone-responsive
reporter gene, pRS423-FUS1prom-lacZ (Hoffman et al., 2002).
Selection for Loss-of-Function Alleles in the DEP Domains
of Sst2
We exploited the fact that sst2D mutations elevate basal signaling in
the pheromone response pathway (Dohlman et al., 1996; Siekhaus
and Drubin, 2003). Hence, we used a his3 strain carrying a phero-
mone-inducible FUS1prom-HIS3 reporter (Horecka and Sprague,
2000) and a low concentration (0.9 mM) of a competitive inhibitor of
His3 (3-aminotriazole; 3-AT), which permitted growth of sst2D, but
not SST2+, cells. To avoid the pheromone-induced cell-cycle block,
we included a specific allele, far1(T306A) (Gartner et al., 1998), that
prevents Far1-imposed cell-cycle arrest but does not disrupt gene
induction (Figure S2). See Supplemental Data for further details.
Selection for Dosage Suppressors of Sst2(Q304N)
An sst2D strain expressing myc-Sst2(Q304N) from the native SST2
promoter onCEN plasmid was transformedwith anS. cerevisiae geno-
mic DNA library carried by a multicopy (2 mm DNA) plasmid, and the
cells were plated on a concentration of pheromone (0.5 nM) that we
determined empirically arrests the growth of sst2D cells expressing
Sst2(Q304N) from the SST2 promoter on a CEN plasmid for several
days yet permits growth of the same cells in the same time period
when Sst2(Q304N) is expressed from amulticopy (2 mmDNA) plasmid.
Candidate library plasmids were rescued and retested, and only those
that allowed growth of recipient cells dependent on the presence of
Sst2(Q304N), but not in its absence, were further characterized. See
Supplemental Data for details.
Interaction Assays
Myc-tagged Sst2 was overexpressed in protease-deficient yeast cells
lacking endogenous Sst2, receptor, and G protein; stripped from the
membrane fraction of lysates of these cells with high salt; and immu-
noaffinity purified. To prepare receptor, the plasmamembrane fraction
of lysates of sst2D cells expressing Ste2 at its endogenous level or
lacking the receptor (ste2D) were purified by flotation through a su-
crose gradient, solubilized with a mild nonionic detergent, and used
immediately to assay binding to immobilized myc-Sst2. His6-Sst2
was produced in insect cells using baculovirus expression, purified
by FPLC, and used for binding to 33 FLAG-tagged Ste2 that was ex-
pressed in sst2D ste2D gpa1D ste4D yeast cells, solubilized with deter-
gent, and immobilized on beads with anti-FLAG epitope mAb. The
split-ubiquitin two-hybrid assay was conducting following established
protocols (Fetchko and Stagljar, 2004). See Supplemental Data for
details.
Fluorescence Microscopy
Cells affixed to microscope slides coated with 0.1 mg/ml concanavalin
A (Sigma Chemical Co., St. Louis) in 10 mMMES (pH 6.0), 1 mMCaCl2
were viewed under a 1003 objective in a DeltaVision Spectris DV4 de-
convolution microscope (Applied Precision LCC, Issaquah, WA, USA).
Images were collected and processed using SoftWoRx imaging soft-
ware (Applied Precision) and Photoshop (Adobe Systems, Inc., San
Jose, CA, USA).
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures,
Supplemental References, two tables, and five figures and can be
found with this article online at http://www.cell.com/cgi/content/full/
126/6/1079/DC1/.
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